Literature DB >> 1085488

Specific and nonspecific cooperation between M-locus-incompatible T and B cells during adoptive anti-hapten antibody responses in mice.

C A Janeway.   

Abstract

CBA and AKR mice are identical at the major histocompatibility locus (H-2) but differ at the strong, non-H-2, mixed leukocyte culture (MLC)-stimulating M-locus. Adoptive secondary in vivo antibody responses using immune spleen cells from mice of these strains demonstrate two interesting findings. One is a non-specific augmentation of the anti-hapten antibody response of CBA B cells by AKR T cells. This allogeneic effect is unidirectional in the same sense as the MLC between cells from these two strains. The second is that, despite an ongoing allogeneic effect, M-locus-incompatible T and B cells show strong specific cooperation. Thus, it seems unlikely that the failure of H-2-incompatible T and B cells to collaborate specifically is due to inhibitory allogenic reactions.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1085488     DOI: 10.1111/j.1365-3083.1976.tb00315.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  4 in total

1.  Immune responses in vitro, XIV. Undetectability of Mlsb- and Mlsc-encoded products on F1 cells possessing Mlsa or Mlsd.

Authors:  R E Click; D Schneider; L A Sitzmann; M M Azar
Journal:  Immunogenetics       Date:  1984       Impact factor: 2.846

2.  MHC recognition by clones of Mls specific T-lymphocytes.

Authors:  B Jones; C A Janeway
Journal:  Immunogenetics       Date:  1982       Impact factor: 2.846

3.  T lymphocytes responding to Mls-locus antigens are Lyt-1+, 2- and I-A restricted.

Authors:  C A Janeway; E A Lerner; J M Jason; B Jones
Journal:  Immunogenetics       Date:  1980       Impact factor: 2.846

4.  Clonal analysis of the Mls system. A reappraisal of polymorphism and allelism among Mlsa, Mlsc, and Mlsd.

Authors:  R Abe; J J Ryan; R J Hodes
Journal:  J Exp Med       Date:  1987-04-01       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.